Abstract
Global Imatinib Drug Market is accounted for xx USD million in 2019 and is expected to reach xx USD million by 2026 growing at a CAGR of xx% during the forecast period. The report offers in-depth insights, revenue details, and other vital information regarding the global Imatinib Drug market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2026.
Imatinib Drug Market report covers size, share and forecast (value and volume) by regions, top players, product types and applications, with historical data along with forecast from 2019 to 2026; The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis.
By geography, this market has been segregated into five regions with revenue and growth rate of Imatinib Drug from 2013 to 2026,
• North America (U.S., Canada, Mexico)
• Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)
• Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)
• Latin America (Brazil, Rest of L.A.)
• Middle East And Africa(Turkey, GCC, Rest of Middle East)
The major players operating into Imatinib Drug Market include:
Novartis
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Cipla Inc.
Apotex Inc.
Mylan Pharms Inc.
etc.
This report segments the Global Imatinib Drug Market as follows:
Global Imatinib Drug Market: Type Segment Analysis
Tablets
Capsules
Global Imatinib Drug Market: Application Segment Analysis
Chronic myelogenous leukemia
Gastrointestinal stromal tumors
Others
There are 13 chapters to put on view for Imatinib Drug Market:
Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation overview
Chapter 2: Market competition by Manufacturers
Chapter 3: Production by Regions
Chapter 4: Consumption by Regions
Chapter 5: Production, By Types, Revenue and Market share by Types
Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications
Chapter 7: Complete profiling and analysis of Manufacturers
Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses
Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10: Marketing Strategy Analysis, Distributors/Traders
Chapter 11: Market Effect Factors Analysis
Chapter 12: Market Forecast
Chapter 13: Imatinib Drug Research Findings and Conclusion, Appendix, methodology and data source
Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export have been determined using secondary sources and verified primary sources. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report.
Industry Chain Analysis
Raw Material and Suppliers
Equipment and Suppliers
Manufacturing Process
Manufacturing Cost Structure
Manufacturing Plants Distribution Analysis
Available Customizations
We can also provide customized report as per company's specific needs. We can also provide the customized separate regional or country-level reports, for the specific region as per client requirement.
Chapter 1 Industry Overview
1.1 Imatinib Drug Market Overview
1.1.1 Imatinib Drug Product Scope
1.1.2 Market Status and Outlook
1.2 Global Imatinib Drug Market Size and Analysis by Regions (2014-2019)
1.2.1 North America Imatinib Drug Market Status and Outlook
1.2.2 EU Imatinib Drug Market Status and Outlook
1.2.3 Japan Imatinib Drug Market Status and Outlook
1.2.4 China Imatinib Drug Market Status and Outlook
1.2.5 India Imatinib Drug Market Status and Outlook
1.2.6 Southeast Asia Imatinib Drug Market Status and Outlook
1.3 Global Imatinib Drug Market Segment by Types (2014-2025)
1.3.1 Global Imatinib Drug Revenue and Growth Rate Comparison by Types (2014-2025)
1.3.2 Global Imatinib Drug Revenue Market Share by Types in 2018
1.3.3 Tablets
1.3.4 Capsules
1.3.5 Type 3
Others
1.4 Imatinib Drug Market by End Users/Application
1.4.1 Global Imatinib Drug Revenue (USD Mn) Comparison by Applications (2014-2025)
1.4.1 Chronic myelogenous leukemia
1.4.2 Gastrointestinal stromal tumors
1.4.3 Others
Others
Chapter 2 Global Imatinib Drug Competition Analysis by Players
2.1 Global Imatinib Drug Market Size (Million USD) by Players (2014-2019)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
Chapter 3 Company (Top Players) Profiles and Key Data
3.1 Novartis
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Novartis, Imatinib Drug Revenue (Million USD) (2014-2019)
3.1.5 Recent Developments
3.2 Glenmark Pharmaceuticals Ltd.
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Glenmark Pharmaceuticals Ltd., Imatinib Drug Revenue (Million USD) (2014-2019)
3.2.5 Recent Developments
3.3 Sun Pharmaceuticals
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Sun Pharmaceuticals, Imatinib Drug Revenue (Million USD) (2014-2019)
3.3.5 Recent Developments
3.4 Actavis Generics
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Actavis Generics, Imatinib Drug Revenue (Million USD) (2014-2019)
3.4.5 Recent Developments
3.5 Dr. Reddy\'s Laboratories
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Dr. Reddy\'s Laboratories, Imatinib Drug Revenue (Million USD)(2014-2019)
3.5.5 Recent Developments
3.6 Teva Pharmaceutical Industries Ltd.
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Teva Pharmaceutical Industries Ltd., Imatinib Drug Revenue (Million USD)(2014-2019)
3.6.5 Recent Developments
3.7 Sanofi S.A.
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Sanofi S.A., Imatinib Drug Revenue (Million USD)(2014-2019)
3.7.5 Recent Developments
3.8 Cipla Inc.
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Cipla Inc., Imatinib Drug Revenue (Million USD) (2014-2019)
3.8.5 Recent Developments
3.9 Apotex Inc.
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Apotex Inc., Imatinib Drug Revenue (Million USD) (2014-2019)
3.9.5 Recent Developments
3.10 Mylan Pharms Inc.
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Mylan Pharms Inc., Imatinib Drug Revenue (Million USD) (2014-2019)
3.10.5 Recent Developments
Chapter 4 Global Imatinib Drug Market Size Type (2014-2019)
4.1 Global Imatinib Drug Market Size by Type (2014-2019)
Chapter 5 Global Imatinib Drug Market Size Application (2014-2019)
5.1 Global Imatinib Drug Market Size by Application (2014-2019)
5.2 Potential Application of Imatinib Drug in Future
5.3 Top Consumer / End Users of Imatinib Drug
Chapter 6 North America Imatinib Drug Development Status and Outlook
6.1 North America Imatinib Drug Market Size (2014-2019)
6.2 North America Imatinib Drug Market Size by Application (2014-2019)
Chapter 7 EU Imatinib Drug Development Status and Outlook
7.1 EU Imatinib Drug Market Size (2014-2019)
7.2 EU Imatinib Drug Market Size by Application (2014-2019)
Chapter 8 Japan Imatinib Drug Development Status and Outlook
8.1 Japan Imatinib Drug Market Size (2014-2019)
8.2 Japan Imatinib Drug Market Size by Application (2014-2019)
Chapter 9 China Imatinib Drug Development Status and Outlook
9.1 China Imatinib Drug Market Size and Forecast (2014-2019)
9.2 China Imatinib Drug Market Size by Application (2014-2019)
Chapter 10 India Imatinib Drug Development Status and Outlook
10.1 India Imatinib Drug Market Size and Forecast (2014-2019)
10.2 India Imatinib Drug Market Size by Application (2014-2019)
Chapter 11 Southeast Asia Imatinib Drug Development Status and Outlook
11.1 Southeast Asia Imatinib Drug Market Size and Forecast (2014-2019)
11.2 Southeast Asia Imatinib Drug Market Size by Application (2014-2019)
Chapter 12 Market Forecast by Regions and Application (2019-2025)
12.1 Global Imatinib Drug Market Size (Million USD) by Regions (2019-2025)
12.1. North America Imatinib Drug Revenue and Growth Rate (2019-2025)
12.1.2 EU Imatinib Drug Revenue and Growth Rate (2019-2025)
12.1.3 China Imatinib Drug Revenue and Growth Rate (2019-2025)
12.1.4 Japan Imatinib Drug Revenue and Growth Rate (2019-2025)
12.1.5 Southeast Asia Imatinib Drug Revenue and Growth Rate (2019-2025)
12.1.6 India Imatinib Drug Revenue and Growth Rate (2019-2025)
12.2 Global Imatinib Drug Market Size by Application (2019-2025)
Chapter 13 Imatinib Drug Market Dynamics
13.1 Imatinib Drug Market Opportunities
13.2 Imatinib Drug Challenge and Risk
13.2.1 Competition from Opponents
13.2.2 Downside Risks of Economy
13.3 Imatinib Drug Market Constraints and Threat
13.3.1 Threat from Substitute
13.3.2 Government Policy
13.3.3 Technology Risks
13.4 Imatinib Drug Market Driving Force
13.4.1 Growing Demand from Emerging Markets
13.4.2 Potential Application
Chapter 14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs Trend/Customer Preference
14.3 External Environmental Change
14.3.1 Economic Fluctuations
14.3.2 Other Risk Factors
Chapter 15 Research Finding /Conclusion
Chapter 16 Methodology and Data Source
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
16.4 Author List
